X-396 (Ensartinib)
Drug timelines are a Plus or Pro feature.
1 regulatory and trial event tracked for X-396 (Ensartinib), covering 2025-07-23 to 2025-07-23. Get the full timeline:
Most recent: Clinical Trial Update: X-396(Ensartinib) Capsules in ALK-Positive NSCLC Patients With Brain Metastases [Phase 2]